No charge unless you’re prescribed.

No charge unless you’re prescribed.

Check eligibility →

Check eligibility →

Rila

Weight Loss

FAQ

Contact

Log in

Get started

Get started

FAQ

Questions, answered

Everything you need to know about getting started with GLP-1 care at Rila.

Am I eligible for GLP-1 treatment?

How does the online visit work?

What are the possible side effects?

What happens if I stop?

Do you take insurance?

Can I cancel anytime?

How soon will my medication arrive?

Important safety information

GLP-1 medications may cause serious side effects, including possible thyroid tumors. Do not use if you or your family have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Common side effects include nausea, vomiting, diarrhea, and constipation. Tell your provider about all medical conditions and medications before starting treatment. If you experience severe side effects, seek medical attention.

How it works

Care in three simple steps

No clinics, no waiting rooms. Get started from your phone and let your care team handle the rest.

Step 01

Take the online quiz

Answer a few questions about your health, history, and goals. It takes about two minutes — no appointment needed.

Step 02

A provider reviews

A US-licensed provider reviews your information and, if it’s appropriate for you, prescribes the right GLP-1 treatment.

Step 03

Delivered to your door

Your medication ships free in discreet packaging, with ongoing check-ins and support between every refill.

What if I’m not approved? You will receive a full refund — no risk to get started.

Get started

Your care team

Our care team is on this journey with you

Every Rila patient is paired with a certified medical assistant (CMA) — your dedicated accountability partner who checks in on your progress, answers questions between visits, and helps you stay consistent every step of the way, at no additional cost.

Patient on a video call with her certified medical assistant from home

Images are illustrative and do not depict actual patients or doctors.

Ready to feel like yourself again?

Take the 2-minute quiz and find out if physician-prescribed GLP-1 treatment is right for you.

Check eligibility

No charge unless prescribed

Discreet packaging & credit card statement

Cancel anytime

24/7 care team support

Rila

Need help?

team@joinrila.com

+1 (801) 210-9432

Treatments

Weight Loss

Company

FAQ

Contact

Refund Policy

Privacy Policy

Terms of Service

SMS Policy

Consent to Telehealth

Rila is a telehealth platform that connects patients with independent, US-licensed healthcare providers. Rila does not provide medical care or prescribe medication; all care decisions are made by independent providers. Prescriptions are issued only after an online consultation and only if a provider determines treatment is appropriate. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Individual results vary; weight-loss outcomes are based on clinical studies of GLP-1 medications combined with diet and exercise. This website does not offer medical advice — consult a qualified healthcare provider with any questions about a medical condition. If you are experiencing a medical emergency, call 911.

Medical provider partners

We are partnered with DrTelx (drtelx.com), an independent telehealth medical group whose providers are licensed in the states where we offer care. We work exclusively with licensed U.S. pharmacies that meet rigorous regulatory and quality standards. Our pharmacy partners include EPIQ Scripts, Foothills Professional Pharmacy, and Emerald Pharmacy. Every pharmacy in our network is licensed in the states where it dispenses, accredited by the National Association of Boards of Pharmacy (NABP), board-certified, and LegitScript-approved. All prescriptions are filled and shipped by these licensed U.S. pharmacies in compliance with applicable state and federal law.

States served

Our telehealth services are available to patients located in all 50 U.S. states and the District of Columbia. All consultations are conducted by licensed U.S. healthcare providers, and all prescriptions are dispensed by licensed U.S. pharmacies. Treatment is only provided where clinically appropriate and permitted by applicable state and federal law. Availability of specific medications may vary by state based on state regulations and provider licensure. Asynchronous (online questionnaire) care is available in the following 44 states: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KY, MA, MD, ME, MI, MN, MO, MT, NC, ND, NE, NH, NJ, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, VT, WA, WI, WY. A live (synchronous) consultation with a provider is required before treatment in these 7 jurisdictions: District of Columbia (DC), Kansas (KS), Louisiana (LA), Mississippi (MS), New Mexico (NM), Rhode Island (RI), West Virginia (WV).

Important safety information

The assessment made available on the Rila website does not create a doctor-patient relationship between the individual completing the assessment and Rila. Rila, a network of US-licensed doctors that adhere to rigorous medical protocols designed for patient safety, has established exclusionary criteria to determine if an individual does not qualify for GLP-1s. The answers an individual provides to the Rila assessment consequently determine if the individual is screened out of eligibility for GLP-1 medication, and a Rila clinician will meet with an individual after checkout to determine if they qualify for a prescription. Rila clinicians retain the decision to prescribe compounded GLP-1s to patients.


All claims and benefits on this website refer to self-reported data from GLP-1 customers on a treatment plan that includes compounded GLP-1 medications and consultations with medical professionals. Customers reported their weight on their initial medical intake questionnaire and every 3-4 weeks thereafter. Results from compounded medications found on the Rila platform may vary and be affected by an individual’s adherence to the program and their clinician’s recommendations. Compounded GLP-1s are produced in FDA-regulated facilities. Although these facilities are highly regulated, the medications are not FDA-approved or evaluated for safety, efficacy, or quality. The decision to use compounded drugs is guided by the licensed provider’s medical judgment, which is informed by a telehealth consultation and medical history.


We encourage all prospective users of compounded medications to speak with their provider about the specific risks and benefits that may come with the use of compounded medication. Rila does not produce compounded medications, and individuals may receive medication that looks different than what is portrayed on the website.

Ozempic®, Wegovy®, Mounjaro® & Zepbound® are trademarks of their respective owners.

© 2026 Rila. All rights reserved.